[go: up one dir, main page]

ES2141671A1 - Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. - Google Patents

Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Info

Publication number
ES2141671A1
ES2141671A1 ES009702698A ES9702698A ES2141671A1 ES 2141671 A1 ES2141671 A1 ES 2141671A1 ES 009702698 A ES009702698 A ES 009702698A ES 9702698 A ES9702698 A ES 9702698A ES 2141671 A1 ES2141671 A1 ES 2141671A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
preparing
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009702698A
Other languages
English (en)
Other versions
ES2141671B1 (es
Inventor
Clotet Joan Huguet
Acin Joan Roca
Rovira Anna Bosch
Bonet Merce Canovas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES9702698A priority Critical patent/ES2141671B1/es
Publication of ES2141671A1 publication Critical patent/ES2141671A1/es
Application granted granted Critical
Publication of ES2141671B1 publication Critical patent/ES2141671B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuesto pirimidínico activo sobre el sistema nervioso central, procedimiento para su preparación y composiciones farmacéuticas que lo contienen. La presente invención se refiere a un compuesto de fórmula general (I), sus formas estereoisoméricas o mezclas de ellas, y sus sales farmacéuticamente aceptables; a un procedimiento para su obtención y a composiciones farmacéuticas que los contengan. Estos compuestos actúan como antagonistas de los receptores D{sub,2 de la dopamina y 5HT{sub,2 de la serotonina y son eficaces en el tratamiento de la esquizofrenia y otras psicosis relacionadas.
ES9702698A 1997-12-26 1997-12-26 Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. Expired - Lifetime ES2141671B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9702698A ES2141671B1 (es) 1997-12-26 1997-12-26 Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9702698A ES2141671B1 (es) 1997-12-26 1997-12-26 Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Publications (2)

Publication Number Publication Date
ES2141671A1 true ES2141671A1 (es) 2000-03-16
ES2141671B1 ES2141671B1 (es) 2001-01-01

Family

ID=8301630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9702698A Expired - Lifetime ES2141671B1 (es) 1997-12-26 1997-12-26 Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

Country Status (1)

Country Link
ES (1) ES2141671B1 (es)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0368388A2 (en) * 1988-11-07 1990-05-16 Janssen Pharmaceutica N.V. 3-Piperidinyl-1,2-benzisoxazoles
EP0453042A1 (en) * 1990-04-19 1991-10-23 Janssen Pharmaceutica N.V. Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
WO1995014691A1 (en) * 1993-11-23 1995-06-01 Janssen Pharmaceutica N.V. NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
WO1995023144A1 (es) * 1994-02-24 1995-08-31 Vita-Invest, S.A. Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0368388A2 (en) * 1988-11-07 1990-05-16 Janssen Pharmaceutica N.V. 3-Piperidinyl-1,2-benzisoxazoles
EP0453042A1 (en) * 1990-04-19 1991-10-23 Janssen Pharmaceutica N.V. Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
WO1995014691A1 (en) * 1993-11-23 1995-06-01 Janssen Pharmaceutica N.V. NOVEL 9-HYDROXY-PYRIDO[1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
WO1995023144A1 (es) * 1994-02-24 1995-08-31 Vita-Invest, S.A. Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Adv. Heterocyclic Chem., Vol. 6, 1996, R.E. LYLE y P.S. ANDERSON "The Reduction of Nitrogen Heterocycles with Complex Metal Hydrides". Pagina 55. *
J. JACQUES et al. "Enantiomers, Racemates and Resolutions", 1991, Krieger Publishing Company, Florida (USA). Paginas 263-266. *

Also Published As

Publication number Publication date
ES2141671B1 (es) 2001-01-01

Similar Documents

Publication Publication Date Title
MY139296A (en) CRYSTALLINE ß2 ADRENERGIC RECEPTOR AGONIST
MXPA05012678A (es) Forma cristalina del agonista del receptor adrenergico beta2.
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
JO2371B1 (en) 4-phenyl-pyridine derivatives
MXPA05009367A (es) Antagonistas del receptor opioide.
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MY124390A (en) Substituted bicyclic derivatives useful as anticancer agents
PL361361A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
CZ305838B6 (cs) N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6
CA2246839A1 (en) Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
MY140835A (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
YU53100A (sh) Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
ES2160525A1 (es) Derivados de la 4-aroilpiperidina antagonistas de los receptores ccr-3
ES2158813A1 (es) Sales cuaternarias de piperidina antagonistas del receptor ccr-3
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
IL142893A0 (en) Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
CA2360308A1 (en) Glucocorticoid receptor modulators
EP0915094A4 (en) MORPHINANE DERIVATIVES AND MEDICAL USE THEREOF
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
MXPA04005426A (es) Derivados de pirazol de anillos fuisionados.
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
MXPA04005076A (es) Derivados de 4-piperidinil alquilamina como antagonistas del receptor muscarinico.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000316

Kind code of ref document: A1

Effective date: 20000316

FA2A Application withdrawn

Effective date: 20031120